Manola, Kalliopi N <br/><br/>
Disruption of the ETV6 gene as a consequence of a rare translocation (12;12)(p13;q13) in treatment-induced acute myeloid leukemia after breast cancer.  [electronic resource] 

 -  Cancer genetics and cytogenetics  Jan 2008 
 - 37-42 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>0165-4608 
<br/><br/><label>Standard No.: </label>10.1016/j.cancergencyto.2007.09.004  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Breast Neoplasms--drug therapy<br/>Chromosome Aberrations<br/>Chromosomes, Human, Pair 12<br/>Female<br/>Gene Fusion<br/>Humans<br/>In Situ Hybridization, Fluorescence<br/>Leukemia, Myeloid, Acute--chemically induced<br/>Proto-Oncogene Proteins c-ets--genetics<br/>Repressor Proteins--genetics<br/>Translocation, Genetic<br/>ETS Translocation Variant 6 Protein